Dana-Farber leader, Laurie H. Glimcher, is recipient of public service award

Posted date

Dana-Farber Cancer Institute President and CEO, Laurie H. Glimcher, MD, has been recognized by the Boston Municipal Research Bureau (BMRB) with the 2020 Henry L. Shattuck Public Service Award – Champion of Business. The award honors individuals who provide dedicated public service to the city of Boston and the community.

In addition to becoming the Institute’s first female President and CEO, Glimcher also has a distinguished career in immunologic cancer research. She identified key transcriptional regulators of protective immunity and the origin of pathophysiologic immune responses underlying autoimmune, infectious, and malignant diseases. Her lab focuses on molecular pathways that regulate CD4 T helper cell development and activation.

In giving Glimcher this award, the BMRB recognizes that Glimcher continues to advocate for improved access to health care and medical education, and that she serves as a mentor and role model for cancer research trainees and for women in science.

Along with Glimcher, 10 Boston employees and a Champion of Non-Profit were honored in a virtual ceremony on Oct. 6th  

The Henry L. Shattuck Public Service Awards acknowledge individuals who exemplify “the integrity, initiative, leadership, and commitment to the public good that Henry L. Shattuck personified as Chairman of the Research Bureau.” The Bureau uses these awards to thank the department heads, peers, and business leaders who have provided outstanding public service to Boston.

For 35 years, the Shattuck awards have celebrated extraordinary individuals for their dedicated service to the City of Boston and the Boston community.

Learn more about the Shattuck Awards.

Related Doctors and Researchers

Media Contacts

If you are a journalist and have a question about this story, please call 617-632-4090 and ask to speak to a member of the media team, or email media@dfci.harvard.edu.

The Media Team cannot respond to patient inquiries. For more information, please see Contact Us.